Physician profile
Bing Liu
NPI 1609659606
$6,772.45
in general payments reported to CMS, 2019-2025
15 companies · $3,240 in 2025
The $3,240 reported for 2025 was more than what 97% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $456 · 2024: $3,076 · 2025: $3,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,759 · Education: $13.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,758.93 |
| Education | $13.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $1,249.31 | 2023-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $1,025.98 | 2023-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Abbvie INC. | $859.88 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $774.98 | 2024-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Vanda Pharmaceuticals INC. | $591.10 | 2024-2025 | Fanapt, Hetlioz |
| Alkermes, INC. | $537.60 | 2023-2025 | Aristada, Lybalvi |
| Supernus Pharmaceuticals, INC. | $379.75 | 2024-2025 | Qelbree |
| Axsome Therapeutics, INC. | $360.37 | 2024-2025 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $292.07 | 2024-2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $291.69 | 2024-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $219.67 | 2024-2025 | Invega, Spravato, Invega Sustenna |
| Indivior INC. | $97.44 | 2024-2025 | Perseris, Sublocade |
| Lundbeck LLC | $51.32 | 2024 | Rexulti |
| Corium, LLC | $22.95 | 2025 | Azstarys |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $18.34 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bing Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.